Accelerating Cancer Research: Patient Derived Xenograft Model Market Opportunities, Size & Forecast 2031
The Patient‑Derived Xenograft Model Market is becoming a critical pillar in oncology research and drug discovery as global demand for predictive preclinical platforms continues to rise. According to the latest market intelligence, the Patient‑Derived Xenograft Model Market was valued at US$ 468.75 million in 2024 and is projected to reach US$ 1,119.36 million by 2031, reflecting a compound...
0 Yorumlar 0 hisse senetleri 206 Views 0 önizleme